Objectives. We report a case of orofacial granulomatosis successfully treated with low-level laser therapy ( LLLT). Study design. LLLT was delivered through a diode laser device (Lasemar Eufoton, Trieste, Italy) with the use of a 4-cm defocalized lens and power of 1 W. Treatment was administered in sessions of 5 irradiations of 1 minute each, with a 1-minute interval between 2 subsequent irradiations (power density 0.08 W/cm(2); fluence/application: 4.8 J/cm(2); fluence/ session: 24 J/cm(2)). Laser therapy was repeated 12 times (3 times per week). Results. After 2 weeks of LLLT applications, the patient reported an improvement of symptomatology as well as a decrease of labial swelling. Complete healing was observed after 1 month. The patient was followed for 2 years. No recurrence of swelling was observed during the follow-up. Conclusions. Advantages of the LLLT approach include an absence of side effects, analgesic properties (usually reported after first application), and good patient compliance.

Orofacial granulomatosis treated with low-level laser therapy: a case report / E. Merigo, C. Fornaini, M. Manfredi, M. Meleti, F. Alberici, L. Corcione, C. Buzio, J. Rocca, T. Ferri, P. Vescovi. - In: ORAL SURGERY, ORAL MEDICINE, ORAL PATHOLOGY AND ORAL RADIOLOGY. - ISSN 2212-4403. - 113:6(2012 Jun), pp. e25-29e.

Orofacial granulomatosis treated with low-level laser therapy: a case report

F. Alberici;
2012

Abstract

Objectives. We report a case of orofacial granulomatosis successfully treated with low-level laser therapy ( LLLT). Study design. LLLT was delivered through a diode laser device (Lasemar Eufoton, Trieste, Italy) with the use of a 4-cm defocalized lens and power of 1 W. Treatment was administered in sessions of 5 irradiations of 1 minute each, with a 1-minute interval between 2 subsequent irradiations (power density 0.08 W/cm(2); fluence/application: 4.8 J/cm(2); fluence/ session: 24 J/cm(2)). Laser therapy was repeated 12 times (3 times per week). Results. After 2 weeks of LLLT applications, the patient reported an improvement of symptomatology as well as a decrease of labial swelling. Complete healing was observed after 1 month. The patient was followed for 2 years. No recurrence of swelling was observed during the follow-up. Conclusions. Advantages of the LLLT approach include an absence of side effects, analgesic properties (usually reported after first application), and good patient compliance.
Melkersson-Rosenthal-syndrome; crohns-disease; irradiation; fibroblasts; thalidomide; infliximab; expession; management; releasse; growth
Settore MED/14 - Nefrologia
giu-2012
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S2212440312000284-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 1.85 MB
Formato Adobe PDF
1.85 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/646919
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 9
social impact